TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2

Raquel Rodrigues-Díez1, Sandra Rayego-Mateos1, Macarena Orejudo1

  • 1Cellular Biology in Renal Diseases Laboratory, School of Medicine, Universidad Autónoma Madrid, 28040 Madrid, Spain.

Insights

Connective tissue growth factor (CCN2) can worsen kidney disease. Blocking TGF-β, thought to promote fibrosis, actually worsened CCN2-induced kidney inflammation and injury in mice.

Area of Science:

  • Nephrology
  • Immunology
  • Cell Biology

Background:

  • Connective tissue growth factor (CCN2) is implicated in renal disease pathogenesis, potentially mediating inflammation and fibrosis.
  • Transforming growth factor-beta (TGF-β) is a key fibrogenic cytokine, but its role in CCN2-driven pathology and its own anti-inflammatory properties remain incompletely understood.

Purpose of the Study:

  • To investigate the impact of TGF-β blockade on experimental renal damage induced by CCN2.
  • To elucidate the mechanisms underlying TGF-β's role in CCN2-mediated kidney injury and inflammation.

Main Methods:

  • Systemic administration of the CCN2 C-terminal module to induce renal inflammation in mice.
  • Treatment with an anti-TGF-β neutralizing antibody to block TGF-β activity.
  • Assessment of renal NGAL expression, monocyte/macrophage infiltration, MCP-1 levels, and circulating Treg cell populations (CD4+/Foxp3+).

Main Results:

  • CCN2 administration led to sustained renal inflammation.
  • TGF-β blockade significantly exacerbated kidney injury, indicated by increased NGAL expression and monocyte/macrophage infiltration.
  • Blocking TGF-β also upregulated MCP-1 expression and decreased circulating regulatory T cells (Tregs), suggesting immune dysregulation.

Conclusions:

  • The study demonstrates that TGF-β exerts protective anti-inflammatory effects in the kidney during CCN2-induced damage.
  • TGF-β blockade is not an optimal therapeutic strategy for this model of renal injury.
  • These findings highlight the complex role of TGF-β in kidney disease and suggest caution in targeting it therapeutically.

Related Concept Videos

Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.3K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.3K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.0K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.1K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K